Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemische Fabrik Budenheim is a prominent global specialty chemical company specializing in high-quality phosphate-based solutions for the pharmaceutical, food, and industrial sectors. In the life sciences industry, the company is a leading provider of high-purity functional excipients, particularly for solid oral dosage forms, where their products act as binders, fillers, and disintegrants. They are widely recognized for their DI-CAFOS brand of calcium phosphates, which are engineered for direct compression and other complex tableting processes. Beyond excipients, Budenheim produces mineral-based active pharmaceutical ingredients (APIs) used in the treatment of mineral deficiencies and bone health. The company operates under stringent Good Manufacturing Practice (GMP) standards and supports global customers with regulatory documentation and tailored chemical engineering solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Budenheim.